Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Am J Gastroenterol
    June 2024
  1. THABUT D, Rudler M, Weiss N
    Diagnosis of Overt Hepatic Encephalopathy With a New Algorithm: Follow-up Data Are Required.
    Am J Gastroenterol. 2024 Jun 3. doi: 10.14309/ajg.0000000000002856.
    >> Share

  2. PAIK JM, Duong S, Zelber-Sagi S, Lazarus JV, et al
    Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
    Am J Gastroenterol. 2024;119:1089-1101.
    >> Share

    May 2024
  3. DANPANICHKUL P, Ng CH, Muthiah M, Suparan K, et al
    From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women.
    Am J Gastroenterol. 2024;119:893-909.
    >> Share

    April 2024
  4. BAJAJ JS, Pimentel M
    Is Hepatic Encephalopathy the First True Disorder of Gut-Brain interaction?
    Am J Gastroenterol. 2024 Apr 22. doi: 10.14309/ajg.0000000000002824.
    >> Share

  5. HUME SJ, Holmes JA, Thompson AJ
    Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of Hepatic Decompensation?
    Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
    >> Share

  6. ERMINELLI D, Mangini C, Zarantonello L, Angeli P, et al
    Overt hepatic encephalopathy - more than meets the eye.
    Am J Gastroenterol. 2024 Apr 8. doi: 10.14309/ajg.0000000000002795.
    >> Share

  7. KHANNA S, Shah NL, Argo CK
    Use of Phosphatidylethanol Testing in Patients With Liver Disease.
    Am J Gastroenterol. 2024;119:596-599.
    >> Share

  8. PERUMALSWAMI PV, Winder GS, Fernandez AC, Mellinger JL, et al
    Practical Considerations to Optimize Care for Patients With Alcohol-Associated Liver Disease in General Gastroenterology Practice.
    Am J Gastroenterol. 2024;119:591-595.
    >> Share

    March 2024
  9. CHEN YT, Chen TI, Yang TH, Yin SC, et al
    Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002778.
    >> Share

  10. CHEN QF, Chen S, Yi JZ, Wang JL, et al
    Recommended Ten Years' Follow-Up Strategy for Small Hepatocellular Carcinoma after Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002774.
    >> Share

  11. LO GH, Yeh JH, Tseng CH, Chen TH, et al
    A non-inferiority trial comparing 2 days vs. 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastro-esophageal variceal hemorrhage.
    Am J Gastroenterol. 2024 Mar 25. doi: 10.14309/ajg.0000000000002776.
    >> Share

  12. TABISH M, Agarwal S, Gopi S, Rana R, et al
    Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
    Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
    >> Share

  13. SAMALA N, Xin Y, Wilson LA, Yates K, et al
    Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002756.
    >> Share

  14. HIRODE G, Hansen BE, Chen CH, Su TH, et al
    Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
    Am J Gastroenterol. 2024 Mar 8. doi: 10.14309/ajg.0000000000002718.
    >> Share

  15. ZHANG X, Daniel CR, Soltero V, Vargas X, et al
    A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients.
    Am J Gastroenterol. 2024;119:505-511.
    >> Share

    February 2024
  16. SASAKI S, Schmidt S, Uldry E, Halkic N, et al
    Hepaticocholecystic Duct: Not a Myth but a Pitfall in Cholecystectomy.
    Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002725.
    >> Share

  17. LOUISSAINT J, Vargas HE
    Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002659.
    >> Share

  18. BUI H, Kumar NG, Singal AG, Boparai J, et al
    Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
    Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
    >> Share

  19. RANGRAY R
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:248.
    >> Share

  20. BATHEJA MA
    Continuing Medical Education Questions: February 2024.
    Am J Gastroenterol. 2024;119:247.
    >> Share

  21. MURPHY CC, Tavakkoli A, Wani S, Singal AG, et al
    Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
    Am J Gastroenterol. 2024;119:382-387.
    >> Share

  22. JULIEN J, Ayer T, Tapper EB, Chhatwal J, et al
    The Rising Costs of Alcohol-Associated Liver Disease in the United States.
    Am J Gastroenterol. 2024;119:270-277.
    >> Share

    January 2024
  23. GE J, Chen IY, Pletcher MJ, Lai JC, et al
    How I Approach It: Prompt Engineering for Generative Artificial Intelligence (GAI) in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002689.
    >> Share

  24. CHARA BS, Hara KS, Penrice D, Schmidt KA, et al
    ARTIFICIAL INTELLIGENCE-ENABLED STOOL ANALYSIS FOR LACTULOSE TITRATION ASSISTANCE IN HEPATIC ENCEPHALOPATHY VIA A SMARTPHONE APPLICATION.
    Am J Gastroenterol. 2024 Jan 19. doi: 10.14309/ajg.0000000000002656.
    >> Share

  25. BLOOM PP, Bajaj JS
    The Current and Future State of Microbiome Therapeutics in Liver Disease.
    Am J Gastroenterol. 2024;119.
    >> Share

  26. KARNA R
    Continuing Medical Education Questions: January 2024.
    Am J Gastroenterol. 2024;119:27.
    >> Share

  27. NICOLETTI P, Dellinger A, Li YJ, Barnhart H, et al
    HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans.
    Am J Gastroenterol. 2024;119:200-202.
    >> Share

    December 2023
  28. FAGAN A, Gallagher ML, Mousel T, Davis BC, et al
    AI evaluation of Stool Quality Guides Management of Hepatic Encephalopathy using a Smartphone App.
    Am J Gastroenterol. 2023 Dec 28. doi: 10.14309/ajg.0000000000002646.
    >> Share

  29. MUI BG, Grinspan LT, Crismale JF
    Variations in practice among cirrhotic patients with portal vein thrombosis and esophageal varices: a North American survey study.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002640.
    >> Share

  30. MULGAONKAR A, Huang DQ, Siddiqi H, Fowler K, et al
    Cost-Effectiveness Analysis of HCC Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis using US Visualization Score C-Triggered Abbreviated MRI.
    Am J Gastroenterol. 2023 Dec 26. doi: 10.14309/ajg.0000000000002636.
    >> Share

  31. PRICE JC, Springer G, Seaberg EC, Budoff MJ, et al
    High incidence rate of CT-measured steatotic liver disease in men with and without HIV infection.
    Am J Gastroenterol. 2023 Dec 22. doi: 10.14309/ajg.0000000000002633.
    >> Share

  32. LEE JD, Gounko D, Lee JA, Mukherjee T, et al
    Assisted Reproductive Technology Treatment Outcomes in Women With Liver Disease.
    Am J Gastroenterol. 2023;118:2184-2190.
    >> Share

    November 2023
  33. DAHER D, El Dahan KS, Yekkaluri S, Gopal P, et al
    Proportion Time Covered by Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002596.
    >> Share

  34. HASHMI I, Chadha N, McIntosh G, Sterling R, et al
    Quality Improvement for Health Care Providers in Gastroenterology and Hepatology.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002609.
    >> Share

  35. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
    Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
    Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
    >> Share

  36. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
    Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
    Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
    >> Share

  37. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
    Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
    Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
    >> Share

  38. WANG B, Zhou J, Wu X, Sun Y, et al
    Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
    Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
    >> Share

  39. YAGHOOBI M
    Continuing Medical Education Questions: November 2023.
    Am J Gastroenterol. 2023;118:1925.
    >> Share

  40. KIM J, Zhang Y, Kim H, Zhang Y, et al
    A Comparative Study of Healthy Dietary Patterns for Incident and Fatal Digestive System Cancer.
    Am J Gastroenterol. 2023;118:2061-2070.
    >> Share

  41. SQUIZZATO F, Abruzzino G, Piazza M
    Acute Liver Failure in a Patient With Previous Vascular Surgery for Bowel Ischemia.
    Am J Gastroenterol. 2023;118:1919.
    >> Share

  42. CHO Y, Chang Y, Ryu S, Kim C, et al
    History of Gestational Diabetes and Incident Nonalcoholic Fatty Liver Disease: The Kangbuk Samsung Health Study.
    Am J Gastroenterol. 2023;118:1980-1988.
    >> Share

    October 2023
  43. LV XH, Lu Q, Deng K, Yang JL, et al
    Prevalence and characteristics of covert/minimal hepatic encephalopathy in patients with liver cirrhosis: A systematic review and meta-analysis.
    Am J Gastroenterol. 2023 Oct 19. doi: 10.14309/ajg.0000000000002563.
    >> Share

  44. SILKE L, Donata G, Dominik G, Uli F, et al
    Endoscopic features of post-COVID-19 cholangiopathy and its management using ERCP.
    Am J Gastroenterol. 2023 Oct 16. doi: 10.14309/ajg.0000000000002562.
    >> Share

  45. OZTURK NB, Jamil LH, Tapper EB
    Diagnostic Performance of the ICD-10 Code K76.82 for Hepatic Encephalopathy in Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 13. doi: 10.14309/ajg.0000000000002560.
    >> Share

  46. PRASOPPOKAKORN T, Panarat P
    Disseminated Melioidosis infection involving hepatosplenomegaly and massive extramedullary hematopoiesis.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002549.
    >> Share

  47. PULASKI M, Bittermann T, Taddei TH, Kaplan DE, et al
    The Association between Homelessness and Key Liver-Related Outcomes in Veterans with Cirrhosis.
    Am J Gastroenterol. 2023 Oct 2. doi: 10.14309/ajg.0000000000002535.
    >> Share

  48. ONG J, Mandour MO, Allison M
    Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1899.
    >> Share

    September 2023
  49. NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al
    Osteoporosis and fragility fractures in patients with cirrhosis evaluated for liver transplantation: Identification of high-risk patients based on computed tomography at evaluation.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507.
    >> Share

  50. FENG X, Li H, Bajaj J, Moon AM, et al
    Endoscopic Ultrasound (EUS)-guided Sclerotherapy with Lauromacrogol: A Novel Therapy for A Giant Esophageal Hemangioma.
    Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002514.
    >> Share

  51. ZHOU R, Zhang B, Gu Y, Li J, et al
    A Promising Digital Therapeutics for Nonalcoholic Steatohepatitis: More Efforts Are Needed.
    Am J Gastroenterol. 2023;118:1704-1705.
    >> Share

  52. LIAW YF
    Impact of ALT Changes on the Risk of HCC in Hepatitis B-Compensated Cirrhotic Patients With Low Viremia.
    Am J Gastroenterol. 2023;118:1701.
    >> Share

  53. RAMKISSOON R, Codipilly DC, Kane SV
    Gastric Outlet Obstruction From a Massive Liver Abscess.
    Am J Gastroenterol. 2023;118:1539.
    >> Share

  54. MEYERS MH, Rodriguez L, Kriss MS
    A Practical Approach to the Management of Gastric Antral Vascular Ectasia.
    Am J Gastroenterol. 2023;118:1532-1535.
    >> Share

  55. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Pike F, et al
    Significant Dose-Response Association of Physical Activity and Diet Quality With Mortality in Adults With Suspected NAFLD in a Population Study.
    Am J Gastroenterol. 2023;118:1576-1591.
    >> Share

    August 2023
  56. RATHI S, Kalantri A, Shastri A, Shree R, et al
    Endoscopic Ultrasound Guided Transgastric Shunt Obliteration (ETSO) for Recurrent Hepatic Encephalopathy.
    Am J Gastroenterol. 2023 Aug 17. doi: 10.14309/ajg.0000000000002477.
    >> Share

  57. KANWAL F, Nelson R, Liu Y, Kramer JR, et al
    Cost of Care for Patients with Cirrhosis.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002472.
    >> Share

  58. YEO YH, Liang J, Lauzon M, Luu M, et al
    Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002467.
    >> Share

  59. TAPPER EB, Zhao Z, Parikh ND
    An emulated clinical trial of deprescribing proton pump inhibitors in patients with cirrhosis.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002462.
    >> Share

  60. WANG M, Cedars MI, Mehta N, Sarkar M, et al
    How I Approach Hepatocellular Adenomas in Hormonally Distinct Populations: Time to Think Outside the (Contraceptive Pill) Box.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002456.
    >> Share

  61. CHEN WC, Yang TC, Lee PC, Wang YP, et al
    A randomized controlled trial of propranolol use during ligation program for secondary prophylaxis of esophageal variceal bleeding.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002457.
    >> Share

  62. ZUO J, Wang W, Li H, Chen C, et al
    Endoscopic submucosal dissection for hypervascularized esophageal squamous cell carcinoma in decompensated cirrhosis with esophageal varices and scars.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002459.
    >> Share

  63. ORMAN ES, Desai AP, Ghabril MS, Nephew LD, et al
    Thirty-day readmissions are largely not preventable in patients with cirrhosis.
    Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002455.
    >> Share

  64. CARROLL AM, Rotman Y
    Nutrition Literacy Is Not Sufficient to Induce Needed Dietary Changes in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:1381-1387.
    >> Share

    July 2023
  65. LARINO-NOIA J, Fernandez-Castroagudin J, de la Iglesia-Garcia D, Lazare H, et al
    Quality of Tissue Samples Obtained by Endoscopic Ultrasound-Guided Liver Biopsy: A Randomized, Controlled Clinical Trial.
    Am J Gastroenterol. 2023 Jul 14. doi: 10.14309/ajg.0000000000002375.
    >> Share

  66. BALLESTER MP, Rose CF, Carbonell-Asins JA, Jalan R, et al
    Measuring and Interpreting Ammonia Levels in Cirrhosis.
    Am J Gastroenterol. 2023;118:1297.
    >> Share

  67. SHINGINA A, Mukhtar N, Wakim-Fleming J, Alqahtani S, et al
    Acute Liver Failure Guidelines.
    Am J Gastroenterol. 2023;118:1128-1153.
    >> Share

    June 2023
  68. WONG F, Kwo P
    Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
    Am J Gastroenterol. 2023;118:915-920.
    >> Share

    May 2023
  69. CONSIGLIERI CF, Puigcerver-Mas M, Garcia-Sumalla A, Gornals JB, et al
    Transpapillary Stent via ERCP Combined with Hepaticoduodenostomy and Gallbladder Drainage for a Complex Hilar Malignant Obstruction.
    Am J Gastroenterol. 2023 May 22. doi: 10.14309/ajg.0000000000002336.
    >> Share

  70. LEAL-VILLARREAL MA, Aguirre-Villarreal D, Vidal-Mayo JJ, Argaiz ER, et al
    Correlation of internal jugular vein (IJV) collapsibility with central venous pressure (CVP) in patients with liver cirrhosis.
    Am J Gastroenterol. 2023 May 4. doi: 10.14309/ajg.0000000000002315.
    >> Share

  71. JANSSON-KNODELL CL, Rubio-Tapia A
    The Liver in Celiac Disease: A Strong 2-Way Talk!
    Am J Gastroenterol. 2023;118:784-785.
    >> Share

  72. YOOSUF S, Singh P, Khaitan A, Strand TA, et al
    Prevalence of Celiac Disease in Patients With Liver Diseases: A Systematic Review and Meta-Analyses.
    Am J Gastroenterol. 2023;118:820-832.
    >> Share

  73. ZHANG H, Jiang B, Meng ZJ
    The Neglected Portal Intrahepatic Shunts.
    Am J Gastroenterol. 2023;118:909.
    >> Share

    April 2023
  74. KUMARI S, De A, Kalra N, Singh V, et al
    Growth Hormone Therapy in Decompensated Cirrhosis: An Open-Label, Randomized Control Trial.
    Am J Gastroenterol. 2023 Apr 27. doi: 10.14309/ajg.0000000000002300.
    >> Share

  75. AVADHANAM M, Kulkarni AV
    Conventional Antibiotics for Spontaneous Bacterial Peritonitis: Are They Still Effective?
    Am J Gastroenterol. 2023;118:613-614.
    >> Share

  76. YIM HJ, Kim TH, Suh SJ, Yim SY, et al
    Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
    Am J Gastroenterol. 2023;118:654-663.
    >> Share

    March 2023
  77. HUANG X, Lin X, Yang S, Chen G, et al
    A rare case of an esophageal mass with varices: esophageal metastasis of hepatocellular carcinoma.
    Am J Gastroenterol. 2023 Mar 28. doi: 10.14309/ajg.0000000000002264.
    >> Share

  78. GAIRING SJ, Mangini C, Zarantonello L, Gioia S, et al
    Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a multicenter study.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002251.
    >> Share

  79. LOZADA MEL ME, Zhang Nz N, Jin Wj W, Wongjarupong Nw N, et al
    CS-iCCA; A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002258.
    >> Share

  80. GHANY MG, Saraswat VA
    Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002224.
    >> Share

  81. KONG X, Kong F, Liu W, Qi K, et al
    From Hepaticogastrostomy to Choledochoduodenostomy: A Rare Stent Migration after EUS-guided Hepaticogastrostomy.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002240.
    >> Share

  82. LIU Y, Guo G, Zheng L, Sun R, et al
    Effectiveness of fenofibrate in treatment-naive patients with primary biliary cholangitis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2023 Mar 9. doi: 10.14309/ajg.0000000000002238.
    >> Share

  83. HAN Q, Han X, Wang X, Wang C, et al
    Association of Accelerometer-Measured Sedentary Behavior Patterns With Nonalcoholic Fatty Liver Disease Among Older Adults: The MIND-China Study.
    Am J Gastroenterol. 2023;118:569-573.
    >> Share

  84. TADDEI TH, Jou JH
    When to Stop Screening-Liver Cancer.
    Am J Gastroenterol. 2023;118:427-428.
    >> Share

  85. ABBAS D, Fix OK, Evon DM, Barritt AS 4th, et al
    Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2023;118:389-393.
    >> Share

    February 2023
  86. FONTANA RJ, Kleiner DE, Chalasani N, Bonkovsky H, et al
    The impact of patient age and corticosteroids in patients with Sulfonamide hepatotoxicity.
    Am J Gastroenterol. 2023 Feb 27. doi: 10.14309/ajg.0000000000002232.
    >> Share

  87. BRANDT LJ
    Use of the Stethoscope to Diagnose Gastrointestinal and Hepatic Disorders.
    Am J Gastroenterol. 2023 Feb 24. doi: 10.14309/ajg.0000000000002233.
    >> Share

  88. N S, N S, M D, H M, et al
    Incidence of cirrhosis among recent immigrants and refugees to Ontario, Canada.
    Am J Gastroenterol. 2023 Feb 8. doi: 10.14309/ajg.0000000000002214.
    >> Share

  89. JEON D, Kim YJ, Kim S, Choi WM, et al
    Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-based Cohort Study.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002209.
    >> Share

  90. VUTIEN P, Li R, Karkar R, Munson SA, et al
    Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") that Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002211.
    >> Share

  91. HAYASHI M, Matsuda M, Yamadera Y, Nakamura J, et al
    Isolated Small Bowel Varices Diagnosed by Contrast-Enhanced Ultrasound.
    Am J Gastroenterol. 2023 Feb 3. doi: 10.14309/ajg.0000000000002184.
    >> Share

  92. MOON AM, Kim HP, Jiang Y, Lupu G, et al
    Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy.
    Am J Gastroenterol. 2023;118:284-293.
    >> Share

  93. KOWDLEY KV, Bowlus CL, Levy C, Mayo MJ, et al
    Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2023;118:232-242.
    >> Share

    January 2023
  94. HIRODE ASG, Hansen BE, Chen CH, Su TH, et al
    Incidence of hepatic decompensation after nucleos(t)ide analogue withdrawal: Results from a large, international, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study).
    Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002203.
    >> Share

  95. STINE JG, DiJoseph K, Pattison Z, Harrington A, et al
    Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Clinically Significant Body Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2023 Jan 30. doi: 10.14309/ajg.0000000000002098.
    >> Share

  96. SATO M, Akamatsu M, Shima T, Ikegami T, et al
    Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial.
    Am J Gastroenterol. 2023 Jan 20. doi: 10.14309/ajg.0000000000002143.
    >> Share

  97. ADEJUMO A, Noll A, Rogal SS, Yakovchenko V, et al
    Dementia frequently co-exists with hepatic encephalopathy but not other cirrhosis complications in US Veterans.
    Am J Gastroenterol. 2023 Jan 17. doi: 10.14309/ajg.0000000000002189.
    >> Share

  98. ZHAO Y, Yeo YH, Samaan J, Lv F, et al
    Racial and ethnic disparities in years of potential life loss among patients with cirrhosis during the COVID-19 pandemic in the United States.
    Am J Gastroenterol. 2023 Jan 13. doi: 10.14309/ajg.0000000000002191.
    >> Share

  99. YANG J, Choi WM, Shim JH, Lee D, et al
    Low level of hepatitis B viremia compared with undetectable viremia increases the risk of hepatocellular carcinoma in patients with untreated compensated cirrhosis.
    Am J Gastroenterol. 2023 Jan 9. doi: 10.14309/ajg.0000000000002181.
    >> Share

  100. DE VEER RC, van Hooff MC, Corpechot C, Thorburn D, et al
    Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
    Am J Gastroenterol. 2023 Jan 9. doi: 10.14309/ajg.0000000000002128.
    >> Share

  101. JUNG J, Nguyen MH
    Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen- Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development.
    Am J Gastroenterol. 2023;118:24-25.
    >> Share

    December 2022
  102. JIRAPINYO P, Zucker SD, Thompson CC
    Regression of Hepatic Fibrosis Following Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022 Dec 23. doi: 10.14309/ajg.0000000000002087.
    >> Share

    November 2022
  103. MATCHETT CL, Rattan P, McConnell JP, Donato LJ, et al
    Chylous Ascites: Reassessment of Diagnostic Criteria in Patients With Portal Hypertension.
    Am J Gastroenterol. 2022 Nov 16. pii: 00000434-990000000-00561.
    >> Share

  104. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    >> Share

    October 2022
  105. LEE CM, Yoon EL, Nakajima A, Yoneda M, et al
    A Reappraisal of the Diagnostic Performance of B-Mode Ultrasonography for Mild Liver Steatosis.
    Am J Gastroenterol. 2022 Oct 31. pii: 00000434-990000000-00515.
    >> Share

  106. CARUSO S, Miraglia R, Alonzo L, Farinella M, et al
    A Rare Portopulmonary Arteriovenous Fistula in a Cirrhotic Patient with Portal Hypertension and Inversion of Blood Flow after Liver Transplantation.
    Am J Gastroenterol. 2022 Oct 6. pii: 00000434-990000000-00541.
    >> Share

  107. REAU N, Munoz SJ, Schiano T
    Liver Disease During Pregnancy.
    Am J Gastroenterol. 2022;117.
    >> Share

  108. HE K, Guo LL, Tang H, Peng X, et al
    A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:1621-1631.
    >> Share

  109. JAMALI T, Raasikh T, Bustamante G, Sisson A, et al
    Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials.
    Am J Gastroenterol. 2022;117:1614-1620.
    >> Share

  110. LIU C, Cao Z, Yan H, Wong YJ, et al
    A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
    Am J Gastroenterol. 2022;117:1605-1613.
    >> Share

  111. LIAO KF, Hwang BF, Liu CS, Lai SW, et al
    Aspirin Use and the Risk of Liver Cancer.
    Am J Gastroenterol. 2022;117:1718.
    >> Share

  112. DEVARBHAVI H, Kurien SS, Raj S, Patil M, et al
    Idiosyncratic Drug-Induced Liver Injury Associated With and Without Drug Reaction With Eosinophilia and Systemic Symptoms.
    Am J Gastroenterol. 2022;117:1709-1713.
    >> Share

    September 2022
  113. CAILES DB, Farouque AO, Majumdar AA, Koshy DAN, et al
    Title: Cardiac Dysfunction in the Pathogenesis of Hepatorenal Syndrome.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00535.
    >> Share

  114. LIN TAY PW, Ng CH, Lin SY, Chin YH, et al
    Placebo Adverse Events in Non-Alcoholic Steatohepatitis Clinical Trials. A Pooled Analysis of 2,944 Participants.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00528.
    >> Share

  115. SERPER M, Tapper EB, Kaplan DE, Taddei TH, et al
    Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00513.
    >> Share

  116. GUPTA A, Rana R, Agarwal S, Sharma S, et al
    Assessing the risk of further decompensation and survival in patients with cirrhosis with variceal bleeding as their first decompensation event.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00510.
    >> Share

  117. SINGAL AG, Reig M, Villanueva A
    Emerging Tools for Hepatocellular Carcinoma Surveillance.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00505.
    >> Share

  118. ZACCHERINI G, Baldassarre M, Tufoni M, Nardelli S, et al
    Correction and prevention of hyponatremia in patients with cirrhosis and ascites - Post hoc analysis of the ANSWER study database.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00502.
    >> Share

  119. HAYASHI PH, Lucena MI, Fontana RJ
    RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis.
    Am J Gastroenterol. 2022;117:1387-1389.
    >> Share

  120. TAO Z, Wang H, Du Z, Zhang Y, et al
    Anorectal Variceal Bleeding Treated by Sclerotherapy.
    Am J Gastroenterol. 2022;117:1403.
    >> Share

  121. FAN L, Zhu X, Shingina A, Kabagambe EK, et al
    Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study.
    Am J Gastroenterol. 2022;117:1523-1529.
    >> Share

  122. HERCUN J, Noureddin M, Noureddin N, Eccleston J, et al
    Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2022 Sep 1. pii: 00000434-990000000-00493.
    >> Share

    August 2022
  123. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
    Am J Gastroenterol. 2022 Aug 25. pii: 00000434-990000000-00492.
    >> Share

  124. DEUTSCH-LINK S, Moon AM
    The Ongoing Debate of Serum Ammonia Levels in Cirrhosis: The Good, The Bad, and The Ugly.
    Am J Gastroenterol. 2022 Aug 23. pii: 00000434-990000000-00488.
    >> Share

  125. WENTWORTH BJ, Henry ZH, Siragy HM
    How I Approach It: Adrenal Insufficiency in Cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00445.
    >> Share

  126. BHAVSAR-BURKE I, Guardiola JJ, Hamade N, Gerke S, et al
    Use of a cirrhosis admission order set improves adherence to quality metrics and may decrease hospital length of stay.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00463.
    >> Share

  127. KUTMUTIA R, Tittanegro T, China L, Forrest E, et al
    Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00458.
    >> Share

  128. TANDON P, Pidborochynski T, Abraldes JG, Carbonneau M, et al
    The assessment of driving fitness using an on-road driving evaluation in patients with cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00462.
    >> Share

  129. WONG F
    The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?
    Am J Gastroenterol. 2022;117:1242-1243.
    >> Share

  130. DANIELSEN KV, Wiese S, Busk T, Nabilou P, et al
    Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study.
    Am J Gastroenterol. 2022;117:1269-1278.
    >> Share

  131. LONG A, Magrath M, Mihalopoulos M, Rule JA, et al
    Changes in Epidemiology of Acetaminophen Overdoses in an Urban County Hospital After 20 Years.
    Am J Gastroenterol. 2022;117:1324-1328.
    >> Share

    July 2022
  132. PARK D, Houston K, Duong NK, Dharia N, et al
    REDUCTION IN NOSOCOMIAL INFECTIONS IN PATIENTS with CIRRHOSIS DURING THE COVID-19 ERA COMPARED TO PRE-COVID-19: IMPACT OF MASKING AND RESTRICTING VISITATION?
    Am J Gastroenterol. 2022 Jul 21. pii: 00000434-990000000-00442.
    >> Share

  133. VUTIEN P, Berry K, Feng Z, VoPham T, et al
    Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00435.
    >> Share

  134. ASRANI SK, Hall L, Reddy V, Ogola G, et al
    Comorbid chronic diseases and survival in compensated and decompensated cirrhosis: a population-based study.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00436.
    >> Share

    June 2022
  135. MOON AM, Ioannou GN
    Moving Away from a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance.
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00430.
    >> Share

  136. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    >> Share

  137. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    >> Share

  138. DAJTI E, Ravaioli F, Marasco G, Alemanni LV, et al
    A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00415.
    >> Share

  139. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
    Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:831-834.
    >> Share

  140. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
    Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:927-930.
    >> Share

  141. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
    Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
    Am J Gastroenterol. 2022;117:918-922.
    >> Share

    May 2022
  142. ACHANTA CR, Kinhal SV, Imandi V, Singh A, et al
    Motorized Spiral Enteroscope Guided Biliary Intervention for Treatment of Biliary Obstruction in Patient with HepaticoJejunostomy.
    Am J Gastroenterol. 2022 May 9. pii: 00000434-990000000-00372.
    >> Share

  143. CROCOMBE D, Freemantle N, O'Brien A
    Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:814-815.
    >> Share

  144. MIR BA, Majeed T, Chauhan A
    A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:815.
    >> Share

    April 2022
  145. RASHMI KG, Sahoo J
    Correspondence from Rashmi et al " Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial ".
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00344.
    >> Share

  146. TAPPER EB, Salim N, Baki J, Zhao Z, et al
    Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00331.
    >> Share

  147. YAMASHITA M, Kugiyama T, Takei D, Hara Y, et al
    An Unexpected Case of Fishbone-Induced Liver Abscess Through the Gallbladder.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00328.
    >> Share

  148. RAO A, Rule JA, Hameed B, Ganger D, et al
    Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Am J Gastroenterol. 2022;117:617-626.
    >> Share

  149. KULKARNI AV, Tirumalle S, Premkumar M, Kumar K, et al
    Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
    Am J Gastroenterol. 2022;117:607-616.
    >> Share

    March 2022
  150. SHAHA S, Gao Y, Huang J, Imbertson E, et al
    Successful Treatment of Superior Mesenteric Artery Syndrome with Percutaneous Endoscopic Gastrojejunostomy in a Sarcopenic Patient with Cirrhosis.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00308.
    >> Share

  151. LAMMERT C, Toal E, Mathur K, Khungar V, et al
    Large Hepatic Adenomas and Hepatic Adenomatosis: A multicenter study of risk factors, interventions, and complications.
    Am J Gastroenterol. 2022 Mar 23. pii: 00000434-990000000-00302.
    >> Share

  152. COSTA MS, Agostinho C, Figueiredo P
    Abdominal Wall Invasion of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00288.
    >> Share

  153. VIEIRA BARBOSA J, Milligan S, Frick A, Broestl J, et al
    Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:453-461.
    >> Share

  154. DUARTE-ROJO A, Sejdic E
    Artificial Intelligence and the Risk for Intuition Decline in Clinical Medicine.
    Am J Gastroenterol. 2022;117:401-402.
    >> Share

  155. LEE HL, Lin MC, Yeh FC, Tsai MK, et al
    Klebsiella pneumoniae Invasive Syndrome With Ventriculitis.
    Am J Gastroenterol. 2022;117:372.
    >> Share

    February 2022
  156. UFERE NN, Patzer RE, Kavalieratos D, Louissaint J, et al
    Rural-Urban Disparities in Mortality from Cirrhosis in the United States from 1999 to 2019.
    Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00270.
    >> Share

  157. LEVY MJ, Bendel EC, Bjarnason H, Reisenauer CJ, et al
    Endoscopic Ultrasound Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension.
    Am J Gastroenterol. 2022 Feb 17. pii: 00000434-990000000-00261.
    >> Share

  158. LEONTIADIS GI, Longstreth GF
    Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders.
    Am J Gastroenterol. 2022 Feb 15. pii: 00000434-990000000-00250.
    >> Share

  159. ZHAO Y, Li X, Yang S, Tao Y, et al
    Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.
    >> Share

  160. PENG T, Lu H, Deng L, Li Q, et al
    Diffuse intrahepatic bile duct hamartomas.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00241.
    >> Share

  161. BAJAJ JS, O'Leary JG, Lai JC, Wong F, et al
    Acute-on-Chronic Liver Failure Clinical Guidelines.
    Am J Gastroenterol. 2022;117:225-252.
    >> Share

  162. VAN KLEEF LA, Hofman A, Voortman T, de Knegt RJ, et al
    Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Am J Gastroenterol. 2022;117:311-318.
    >> Share

  163. YU S, Pan L, Ma J, Cao H, et al
    The Underlying Cause of Esophageal Variceal Bleeding: Hereditary Thrombophilia.
    Am J Gastroenterol. 2022;117:217.
    >> Share

    January 2022
  164. YUAN L, Hanlon CL, Terrault N, Alqahtani S, et al
    Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Am J Gastroenterol. 2022 Jan 27. pii: 00000434-990000000-00229.
    >> Share

  165. LOUISSAINT J, Grzyb K, Bashaw L, Mohammad RA, et al
    An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
    Am J Gastroenterol. 2022 Jan 12. pii: 00000434-990000000-00194.
    >> Share

  166. GONZALEZ SA, Velez JCQ
    Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 with Terlipressin.
    Am J Gastroenterol. 2022 Jan 5. pii: 00000434-990000000-00198.
    >> Share

    December 2021
  167. AHN JC, Attia ZI, Rattan P, Mullan AF, et al
    Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00204.
    >> Share

  168. KIM NJ, Rozenberg-Ben-Dror K, Jacob DA, Berry K, et al
    The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system: COVID-19 and HCC screening and diagnosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00201.
    >> Share

  169. HUANG AC, Grab J, Flemming JA, Dodge JL, et al
    Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00172.
    >> Share

  170. VAN DE BRUAENE C, Houthoofd B, De Coninck S
    A Hepatic Change of Mind.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00169.
    >> Share

  171. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    >> Share

  172. LV Y, Bai W, Li K, Wang Z, et al
    Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Dec 9. pii: 00000434-990000000-00159.
    >> Share

  173. LIZAOLA-MAYO BC, Mathur AK, Borad MJ, Jadlowiec CC, et al
    Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:2478-2480.
    >> Share

  174. HARRISON SA, Baum SJ, Gunn NT, Younes ZH, et al
    Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2021;116:2399-2409.
    >> Share

  175. BERK C, Ammar T, Lee BT
    Acute Liver Failure due to Manufactured Alkaline Water: A Case Series of "Real Water"-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:2476-2477.
    >> Share

  176. MEDAS R, Garrido I, Coelho R, Macedo G, et al
    Extensive Abdominal Wall Hematoma After Paracentesis.
    Am J Gastroenterol. 2021;116:2325.
    >> Share

    November 2021
  177. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    >> Share

  178. DAWOD E, Nieto J, Saab S
    Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand?
    Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00146.
    >> Share

  179. DUONG NK, Shrestha S, Park D, Shahab O, et al
    Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
    >> Share

  180. YANG D, Zhuang B, Xie X
    Hepatic Angiofibroma of Soft tissue: A Case Report.
    Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.
    >> Share

  181. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
    Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Am J Gastroenterol. 2021;116:2270-2278.
    >> Share

    October 2021
  182. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.
    >> Share

  183. GAO X, Gao Y, Ye X, Kang W, et al
    Rare Multiple Liver Lesions With Concentric Circle Pattern.
    Am J Gastroenterol. 2021;116:1979.
    >> Share

  184. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    >> Share

  185. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
    Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Am J Gastroenterol. 2021;116:2079-2088.
    >> Share

  186. JOHNSON DA
    "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
    Am J Gastroenterol. 2021;116:1970-1971.
    >> Share

    September 2021
  187. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    >> Share

  188. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    >> Share

  189. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    >> Share

  190. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.
    >> Share

  191. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    >> Share

  192. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    >> Share

  193. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    >> Share

    August 2021
  194. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    >> Share

  195. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.
    >> Share

  196. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
    Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
    >> Share

  197. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
    Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
    Am J Gastroenterol. 2021;116:1741-1745.
    >> Share

  198. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
    Deglutition Syncope After Variceal Band Ligation.
    Am J Gastroenterol. 2021;116:1763.
    >> Share

  199. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
    Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
    Am J Gastroenterol. 2021;116:1667-1675.
    >> Share

    July 2021
  200. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    >> Share

  201. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    >> Share

  202. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.
    >> Share

  203. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    >> Share

  204. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.
    >> Share

  205. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    >> Share

    June 2021
  206. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.
    >> Share

  207. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.
    >> Share

  208. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
    Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
    >> Share

  209. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    >> Share

  210. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.
    >> Share

  211. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.
    >> Share

  212. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.
    >> Share

  213. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.
    >> Share

  214. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.
    >> Share

  215. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    >> Share

    May 2021
  216. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    >> Share

  217. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    >> Share

  218. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    >> Share

  219. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    >> Share

  220. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.
    >> Share

  221. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.
    >> Share

  222. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.
    >> Share

  223. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    >> Share

  224. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    >> Share

  225. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.
    >> Share

  226. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    >> Share

    April 2021
  227. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    >> Share

  228. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    >> Share

  229. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    >> Share

  230. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    >> Share

  231. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    >> Share

  232. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    >> Share

  233. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.
    >> Share

  234. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    >> Share

  235. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.
    >> Share

  236. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.
    >> Share

  237. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    >> Share

  238. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    >> Share

  239. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.
    >> Share

  240. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.
    >> Share

  241. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.
    >> Share

  242. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    >> Share

  243. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    >> Share

    March 2021
  244. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    >> Share

  245. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    >> Share

    February 2021
  246. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016